Optimizing Colorectal Cancer and Polyp Surveillance after Colorectal Polypectomy
优化结直肠息肉切除术后结直肠癌和息肉监测
基本信息
- 批准号:8865084
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-04-01 至 2019-03-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAdenomatous PolypsAdvisory CommitteesAgeAlgorithmsAreaAspirinBudgetsCalibrationCancer EtiologyCaringCessation of lifeCharacteristicsClinicalClinical DataColonColon CarcinomaColonoscopyColorectalColorectal CancerColorectal NeoplasmsColorectal PolypDataData ElementData SetDetectionDietDiscriminationDiseaseDocumentationDysplasiaEffectivenessEnsureExcisionFamilyFeedbackFeesFrequenciesGastroenterologyGoalsGrowthGuidelinesHealthHealthcareHistologyHuman Subject ResearchHyperplastic PolypIndividualInformaticsInterventionIntestinesInvestmentsLabelLeadershipLocationMalignant NeoplasmsManualsMeasuresMedicalMedical RecordsMethodsMinorityModelingMonitorNational Comprehensive Cancer NetworkNational Health Interview SurveyNatural Language ProcessingNeoplasmsOutcomeOutcomes ResearchPathologicPathologyPatientsPerformancePharmaceutical PreparationsPolypectomyPolypsPopulationPreparationPreventionProviderPublicationsRecommendationRecording of previous eventsRecordsRecurrenceReportingResearchResearch InfrastructureResearch PersonnelResourcesRiskRisk AssessmentRisk FactorsSamplingScienceSensitivity and SpecificitySiteSmokingSpecificityStratificationTechniquesTestingTextTherapeuticTrainingUnited StatesValidationVeteransVillousVisualWomanWorkadenomabasecancer diagnosiscancer preventioncancer riskclinical practicecohortcolorectal cancer preventioncolorectal cancer screeningcomputerizedexperiencefollow-uphigh riskimpressionimprovedinnovationinterestmeetingsnovelpredictive modelingprimary outcomered meat consumptionresponsescreeningsex
项目摘要
DESCRIPTION (provided by applicant):
Colorectal cancer (CRC) is the 2nd leading cause of cancer death nationally, and the 3rd most commonly diagnosed cancer among Veterans. To reduce cancer risk, small growths in the colon called polyps found at colonoscopy are routinely removed. Current guidelines recommend repeat colonoscopy in 3, 5, or 10 years based on select features of polyps removed. However, the current approach is not accurate for cancer risk prediction. Late colonoscopy (in 5 or 10 years) is often recommended for individuals who go on to develop cancer or high-risk polyps. Conversely, early colonoscopy (in 3 years) is often recommended for individuals who go on to develop only low-risk findings. The result is suboptimal cancer prevention. The overall goal of this project is to develop a new, more personalized and comprehensive strategy for assessing risk for new polyps and CRC after initial polyp removal, including patient factors (such as age), baseline polyp factors (such as number, size, location), and quality factors (such as average polyp detection rate of the doctor performing colonoscopy). To develop the strategy, national VA colonoscopy and medical record data will be accessed to identify Veterans who have had polyp removal and at least one follow up colonoscopy between 1999 and 2012. At least 30,000 Veterans are expected to meet these criteria. Next, computerized Natural Language Processing (NLP) techniques will be developed to extract risk and outcome data of interest from colonoscopy and pathology records. These innovative techniques are required because the most valuable information available for risk prediction is only available in "free text" format witin these clinical reports. The alternative approach to data extraction (manual review of each Veteran's medical chart) is impractical, and indeed it is for this reason that research in this are has previously not been possible on a large-scale. Application of these NLP techniques will allow creation of a large, representative dataset of all Veterans who have had colonoscopy with polyp removal. In the third part of this research, a statistical risk stratification strategy to prdict risk for polyps and CRC after initial polyp removal will be developed using this dataset. Performance of the new strategy will be compared to current guidelines for predicting risk for CRC and high-risk polyps after initial polyp removal. The project is significant because Veterans are at high risk for CRC, but strategies for managing cancer risk are suboptimal. The project is innovative because we will apply cutting edge NLP methods to make use of data that is representative of all Veterans who have had polyp removal within the VA, and develop risk prediction models that go beyond current guidelines by using more personalized risk measures. The research team's expertise and significant prior work specific to CRC and polyps, and the rigorous approach proposed, ensure that the project is feasible and will be successful. Ultimately, investment in this Merit Review has great potential to improve CRC prevention for Veterans, and beyond. CRITIQUE 1 1. Significance.
NCCN guidelines take into account age (>50) and family history and only recommends a 10 year interval for patients without a FH and with no polyp identified or if hyperplastic polyps are identified. For patients with an adenomatous polyp removed the recommendation varies between 3 years and 5 years based on polyp number, size, and histology (villous or presence of high grade dysplasia). The assertion that colonoscopy is suboptimal for cancer prevention is in part true but primarily due to access issues and compliance with screening and less so due to surveillance intervals . The idea of a personalized interval is already in place and while a little
more difficult in the veteran population, providers still make their recommendations based on individual factors in concert with national guidelines. Efforts to develop a computerized entry form to quantify and record needed information seem more important.
2. Approach
It is unclear if Aim 1 will use path records to only evaluate adenomatous polyps and if so the recommendations only differ by 2 years.
Accepting a low detection rate from a provider/site and/or using that as a risk factor to increase screening frequency seems like a "work around" and more direct quality interventions to monitor and raise detection rates seem more valuable.
The primary endpoint consists of polyp size, polyp number and histology. The discrepancy between endoscopic visual size and pathologic size needs to worked out
3. Impact and Innovation.
Given that the utilization of colon cancer screening is only around 50% nationally (2005 National Health Interview Survey) and with documented capacity issues at some VAs who have limited screening colonoscopy (fee basis) and prioritized therapeutic colonoscopy. Any study findings calling for increased screening may be unfulfilled. This study will evaluate veterans who have had at least two colonoscopies.
4. Investigator Qualifications, and Facilities and Resources.
This is an experienced team.
5. Multiple PI Leadership Plan.
N/A 6. Adequacy of Response to Previous Feedback Provided by HSR&D Regarding the Proposed Study. 7. Protection of Human Subjects from Research Risk.
Adequate 8. Inclusion of Women and Minorities in Research.
Adequate
9. Budget.
Adequate 10. Overall Impression. 11. Key Strengths.
1. Colon cancer prevention is an important area.
2. Good collaborative team with extensive experience
12. Key Weaknesses.
1. This seems like a validation of NLP in a large cohort
2. Information on preventative medications such as aspirin or other dietary risks factors such as red meat consumption and BMI are not addressed
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Samir Gupta其他文献
Samir Gupta的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Samir Gupta', 18)}}的其他基金
Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study
老年人结肠镜检查监测:SurvOlderAdults 研究
- 批准号:
10638065 - 财政年份:2023
- 资助金额:
-- - 项目类别:
CRC-HUB-SPOKE: A ColoRectal Cancer screening Hub for Southern California community health centers.
CRC-HUB-SPOKE:南加州社区健康中心的结肠直肠癌筛查中心。
- 批准号:
10689096 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Abnormal Fecal Test Results Associated with Colorectal Cancer Incidence and Mortality
粪便检测结果异常与结直肠癌发病率和死亡率相关
- 批准号:
10063801 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Post-polypectomy Surveillance for Reducing Colon Cancer Incidence and Mortality
息肉切除术后监测以降低结肠癌发病率和死亡率
- 批准号:
10078600 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Post-polypectomy Surveillance for Reducing Colon Cancer Incidence and Mortality
息肉切除术后监测以降低结肠癌发病率和死亡率
- 批准号:
10595066 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Post-polypectomy Surveillance for Reducing Colon Cancer Incidence and Mortality
息肉切除术后监测以降低结肠癌发病率和死亡率
- 批准号:
10537988 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Optimizing Colorectal Cancer and Polyp Surveillance after Colorectal Polypectomy
优化结直肠息肉切除术后结直肠癌和息肉监测
- 批准号:
10011577 - 财政年份:2015
- 资助金额:
-- - 项目类别:
Optimizing Colorectal Cancer and Polyp Surveillance after Colorectal Polypectomy
优化结直肠息肉切除术后结直肠癌和息肉监测
- 批准号:
9145517 - 财政年份:2015
- 资助金额:
-- - 项目类别:
Project 2: A randomized trial of outreach and inreach strategies for boosting colorectal cancer screening in a Federally-Qualified Health Center primarily serving low income Hispanic/Latinos
项目 2:在主要为低收入西班牙裔/拉丁美洲人服务的联邦合格健康中心进行外展和内展策略的随机试验,以促进结直肠癌筛查
- 批准号:
9349472 - 财政年份:2008
- 资助金额:
-- - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
-- - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
-- - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant